- Home
- VTRS vs GLPI Comparison
VTRS vs GLPI Comparison
Compare VTRS & GLPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- GLPI
- Stock Information
- Founded
- VTRS 1961
- GLPI 2013
- Country
- VTRS United States
- GLPI United States
- Employees
- VTRS N/A
- GLPI N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- GLPI Real Estate Investment Trusts
- Sector
- VTRS Health Care
- GLPI Real Estate
- Exchange
- VTRS Nasdaq
- GLPI Nasdaq
- Market Cap
- VTRS 12.9B
- GLPI 13.7B
- IPO Year
- VTRS N/A
- GLPI N/A
- Fundamental
- Price
- VTRS $11.74
- GLPI $51.76
- Analyst Decision
- VTRS Hold
- GLPI Buy
- Analyst Count
- VTRS 3
- GLPI 16
- Target Price
- VTRS $12.33
- GLPI $51.57
- AVG Volume (30 Days)
- VTRS 6.9M
- GLPI 1.2M
- Earning Date
- VTRS 11-05-2024
- GLPI 10-24-2024
- Dividend Yield
- VTRS 4.12%
- GLPI 5.89%
- EPS Growth
- VTRS N/A
- GLPI 0.14
- EPS
- VTRS N/A
- GLPI 2.89
- Revenue
- VTRS $15,239,200,000.00
- GLPI $1,485,179,000.00
- Revenue This Year
- VTRS N/A
- GLPI N/A
- Revenue Next Year
- VTRS N/A
- GLPI $5.82
- P/E Ratio
- VTRS N/A
- GLPI $17.88
- Revenue Growth
- VTRS N/A
- GLPI 7.47
- 52 Week Low
- VTRS $8.74
- GLPI $41.80
- 52 Week High
- VTRS $13.62
- GLPI $52.60
- Technical
- Relative Strength Index (RSI)
- VTRS 54.19
- GLPI 62.48
- Support Level
- VTRS $10.85
- GLPI $51.47
- Resistance Level
- VTRS $12.10
- GLPI $52.54
- Average True Range (ATR)
- VTRS 0.27
- GLPI 0.74
- MACD
- VTRS -0.02
- GLPI -0.06
- Stochastic Oscillator
- VTRS 74.00
- GLPI 71.43
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.